In pharmaceutical manufacturing, contamination and cross-contamination pose significant risks to product quality, patient safety, and regulatory compliance. These risks primarily arise from inadequate cleaning of equipment, processing areas, or handling of starting materials. Implementing robust cleaning validation protocols minimizes such risks by ensuring that manufacturing equipment is consistently cleaned to predefined and acceptable levels. Cleaning validation is an essential element of Good Manufacturing Practice (GMP) and provides documented evidence that a cleaning procedure is effective, reproducible, and compliant with regulatory standards. This review highlights the various cleaning approaches employed in the pharmaceutical industry and the strategies used for validating those procedures. Critical parameters, sampling methods, and worst-case scenarios are evaluated to verify cleaning efficiency, reduce variability, and maintain consistent quality assurance throughout the manufacturing process.
More et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: